GR3004372T3 - - Google Patents

Info

Publication number
GR3004372T3
GR3004372T3 GR910401922T GR910401922T GR3004372T3 GR 3004372 T3 GR3004372 T3 GR 3004372T3 GR 910401922 T GR910401922 T GR 910401922T GR 910401922 T GR910401922 T GR 910401922T GR 3004372 T3 GR3004372 T3 GR 3004372T3
Authority
GR
Greece
Prior art keywords
alkyl
nitrogen
substituted
chosen
sulphoxide
Prior art date
Application number
GR910401922T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004372T3 publication Critical patent/GR3004372T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR910401922T 1987-07-07 1992-04-16 GR3004372T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/070,389 US4775753A (en) 1987-07-07 1987-07-07 New process for the preparation of pristinamycin IIB derivatives

Publications (1)

Publication Number Publication Date
GR3004372T3 true GR3004372T3 (el) 1993-03-31

Family

ID=22095006

Family Applications (1)

Application Number Title Priority Date Filing Date
GR910401922T GR3004372T3 (el) 1987-07-07 1992-04-16

Country Status (9)

Country Link
US (1) US4775753A (el)
EP (1) EP0298177B1 (el)
JP (1) JP2552299B2 (el)
AT (1) ATE74926T1 (el)
AU (1) AU593363B2 (el)
DE (1) DE3778359D1 (el)
ES (1) ES2033335T3 (el)
GR (1) GR3004372T3 (el)
ZA (1) ZA874938B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2664599B1 (fr) * 1990-07-16 1993-06-18 Rhone Poulenc Sante Vinylsulfonyl pristinamycine et sa preparation.
FR2664600B1 (fr) * 1990-07-16 1994-09-02 Rhone Poulenc Sante Nouveau sel derive de la dialcoylaminoalcoyl-sulfonyl-26 pristinamycine iib.
FR2664598A1 (fr) * 1990-07-16 1992-01-17 Rhone Poulenc Rorer Sa Procede de preparation de sulfinyl pristinamycine iib.
US6881680B2 (en) 2002-06-14 2005-04-19 Toyo Tanso Co., Ltd. Low nitrogen concentration carbonaceous material and manufacturing method thereof
US8309765B2 (en) * 2007-05-04 2012-11-13 United Phosphorus Limited Process for manufacture of high purity D-(−)-N,N-diethyl-2-(α-naphthoxy) propionamide
JP2013001582A (ja) * 2011-06-13 2013-01-07 Kansai Coke & Chem Co Ltd 等方性黒鉛材料及びその製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL203008A (el) * 1954-12-20
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
GB8616768D0 (en) * 1986-07-09 1986-08-13 May & Baker Ltd Process

Also Published As

Publication number Publication date
AU593363B2 (en) 1990-02-08
EP0298177B1 (fr) 1992-04-15
ZA874938B (en) 1988-01-18
DE3778359D1 (de) 1992-05-21
ES2033335T3 (es) 1993-03-16
AU7529587A (en) 1989-01-12
JP2552299B2 (ja) 1996-11-06
EP0298177A1 (fr) 1989-01-11
ATE74926T1 (de) 1992-05-15
JPS6416789A (en) 1989-01-20
US4775753A (en) 1988-10-04

Similar Documents

Publication Publication Date Title
DK0427549T3 (da) Heterocykliske oxy-phenoxyeddikesyrederivater og deres anvendelse som herbicider
IE872615L (en) TRIAZOLO (1,5-c) PYRIMIDINE DERIVATIVES
AU577654B2 (en) Pristinamycin iib derivatives
GR3004372T3 (el)
HU908471D0 (en) Process for the production of fungicide preparations containing pyridyl-cyclopropane derivatives as active agents and process for the production of the active agents
DK166275C (da) Derivater af phenyl, pyrrolidin-2-yl substitueret pyrrol og farmaceutisk acceptable syreadditionssalte heraf med antipsykotiske egenskaber, fremgangsmaade til fremstilling heraf, samt farmaceutiske praeparater indeholdende disse forbindelser
PT85274A (en) Pristinamycin process
GB2254324B (en) Piperazine derivatives
DK141187D0 (da) 1-(3-(2-dialkylaminoethoxy)-2-thienyl)-3-phenyl-1-propanoner og syreadditionssalte deraf, fremgangsmaade af saadanne forbindelser samt farmaceutiske praeparater indeholdende disse
IL86665A0 (en) Mitomycin analogs
DK350187A (da) Fremgangsmaade til fremstilling af pristinamycin iib-derivater